Smallpox Stores

My opinion is that all known stocks of the smallpox virus should be destroyed as soon as possible. I disagree with the premise of the late Bernard Fields's argument (quoted in K.Y. Kreeger, The Scientist, Nov. 14, 1994, page 1) that "destroying it ends the whole issue of possibly understanding it in the future." The only moral, humane reason for a scientist to study a virulent microbe is to obtain the minimum amount of information needed for its eradication_that is, how to create an effective v

Written bySusan Robbins
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

My opinion is that all known stocks of the smallpox virus should be destroyed as soon as possible. I disagree with the premise of the late Bernard Fields's argument (quoted in K.Y. Kreeger, The Scientist, Nov. 14, 1994, page 1) that "destroying it ends the whole issue of possibly understanding it in the future." The only moral, humane reason for a scientist to study a virulent microbe is to obtain the minimum amount of information needed for its eradication_that is, how to create an effective vaccine or treatment. Since the virus has been eliminated from humans, why let it "live" and risk its release by accident or intent?

Those who think it desirable to pursue further knowledge of smallpox replication for what it might shed on understanding other known or emerging viruses are trading a certainty (getting closer to total destruction of smallpox) for a possibility and risking the lives ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies